Synthesis and DFT Study of Newly Schiff Base and Fused Heterocyclic Compounds as Antibacterial Agent

Authors

  • Sameh Rizk University of Ain Shams, Cairo
  • Ismail M. Awheda University of Mergeb, Tripoli
  • Fathi A. Smida University of   El-Mergeb, El-Khoms Lybia

DOI:

https://doi.org/10.24297/jac.v16i0.8499

Keywords:

Oxirane, Pyrazole, Isooxazole, Schiff Base, Imidazole, Triazine

Abstract

Treatment of 2,3-di-(4-chlorophenyl) oxirane-2,3-dicarbonitriles(1) with nitrogen nucleophiles, e.g. N2H4, NH2OH afforded pyrazole 2, 1.2oxazole 3 derivatives respectively The 3-amino pyrazole-4-one derivatives 2 can be used as a key starting materials to synthesize some important Schiff base 4 and fused heterocyclic compounds e.g. Imidazolo-[4,5-c]pyrazole 5, Pyrazolo[3,4-e]1,2,4-triazine 6, pyrazol[1,2-a] 1,3,5-triazine 7, 8 and 9. The electromeric effect of the halogen atom in the aryl moieties can be controlled upon the rate of reaction and the yield of the product. The structures of synthesized new compounds were characterized by spectral data and screened for their antimicrobial activities against various bacteria and fungi strains. The heterocyclic compounds 7, 8 and 9 that contained bridgehead nitrogen gave an excellent result. 

Downloads

Download data is not yet available.

Author Biographies

Sameh Rizk, University of Ain Shams, Cairo

Department of Chemistry, Faculty of Science, University of Ain Shams, Cairo, Egypt.

Ismail M. Awheda, University of Mergeb, Tripoli

Department of Chemistry, Faculty of Art and Science, University of Mergeb, Tripoli, Lybia

Fathi A. Smida, University of   El-Mergeb, El-Khoms Lybia

Department of Chemistry, Faculty of Art and Science, University of   El-Mergeb, El-Khoms Lybia

References

K. Nishiyama, G. W. Griffin, K. Ishikawa, and D. M.Gibson, J. Org. Chem. 1982, 47, 2342. b) L. Zheng, X. Jun, N. Pengxian, L. Chenhui, and Y. Jingya, Tetrahedron, 2012, 68, 8880

G. Daidone, B. Maggio, S. Plescia, D. Raff, C. Musiu, C. Milia, G. Perra, and M. E.Marongiu, Eur. J. Med.chem., 1998, 33,375.

N. Singh, N. K. Sangwan, and K. S. Dhindsa, Pest manage. Sci., 2000, 56, 284.

G. Daidone, D. Raffa, F. Plescia, B. Maggio, and A. Roccaro, Arkivoc 2002, xi, 227.

O. Migliara, S. Plescia, P. Diana, V. Distefano, L. Camarda, and O. R. Dall, Arkivoc 2004, v, 44.

Bouabdallah, L.A. Barek, A. Zayed, A.Ramadani, I. Zidane, and A. Melhaoui, Natural product research, 2006, 20(11), 1024.

S. Nagaaki, J. Makoto, I. Shiho, N. Keita, T. Hiroyasu, A. Makoto, O. Osamu, I. Hisashi, G. Akira, I. Akane, K. Akio, and F. Takehiro, Bioorganic & Medicinal Chemistry Letters 2009, 19, 1670.

P. Dariusz, M. B. Andrzej, E. L. Agnieszk, J. S. Bohdan, and K. Jerzy, Acta Poloniae Pharmaceutica ñ Drug Research, 2007, 64(6) 535.

Ø. Justyna, O. Dorota, Z. Zofia, A. Ewa, and Z. Lucjusz, Acta Poloniae Pharmaceutica ñ Drug Research, 2008, 65, 229.

C. S. Prabodh, V. S. Sunil, J. Sandeep, S. Dalbir, and S. Bhojraj, Acta Poloniae Pharmaceutica ñ Drug Research, 2009, 66(1), 101.

M. Marcin, Z. Michal, T. Magdalena, and R. Stanislaw, Acta Poloniae Pharmaceutica ñ Drug Research, 2008, 65(5): 543.

M. C. Marcin, Z. Michal, A.R. Stanise, Acta Poloniae Pharmaceutica ñ Drug Research, 2008, 65(2), 241.

M. B. Alvarez, M. Palmeri, D. Davis, and J. S. Fritz, Talanta. 1987, 34, 473.

D. K. Johnson, T. B. Murphy, and W. H. Goodwin, Inorg. Chim. Acta 1982, 67, 159.

K. Shreenivasan, S. Perrier, S. Kochi, J. Mol. Catal. 1986, 36, 297.

M. H. Ali, S. E. Livingston: Coord. Chem. Rev. 1974, 13, 126.

M. Jain, S. Nehra, P. C.Trivedi, R. V. Singh, Metal-based drugs 2002, 9, 53.

M. Jain, R.V. Singh, Ind. J. Chem. Sci. 2003, 1, 17.

R.M. Patil, Acta Poloniae Pharmaceutica ñ Drug Research, 2007, 64(4), 345.

R.M. Patil, and N. V. Thakkar, Met. Org. Chem. 2000, 30, 1159.

S. A. Rizk, M. A. EL-Hashash, and M. M. Aburzeza, Egypt. J. Chem. 2011, 54(3), 299.

M. A. El-Hashash, S. A. Rizk, J Heterocyclic Chem 2017, 54, 1776.

S. A. Rizk, M.A. El-Hashash, K. K. Mostafa, Egypt, J. Chem. 2008, 51(5), 116.

S. A. Rizk, Amira A. El-Sayed, and Marwa M. Mounier, J. Heterocyclic Chem., 2017, 54, 3358.

M.E. Azab, S.A. Rizk, A. E. Amr, Molecules 2015, 20, 18201-18218.

D. N. Dhar, The Chemistry of chalcones and related compounds, Wiley-Interscience, New York, 1981, 228

J. R. Dimmock, D. W. Elias, M. A. Beazely, and N. M. Kandepu, Curr. Med. Chem. 1999, 6, 1125–1150.

G.D .Carlo, N. Mascolo, A.A. Izzo,and F. Capasso, Life Sci., 1999, 65(4), 337-353.

S. V. Kostanecki, and Tambor, J. Chem Ber., 1899, 32, 1921

R.K. Saini, A.S. Choudhary, Y.C. Joshi, and P. Joshi, E-J. Chem., 2006, 2(4), 224-227

H. Takayanagri, Y. Kitano, T. Yano, H. Umeki, and H. Hara, J. Can. Pat. Appl. 1995, 93(50),128.

Downloads

Published

2019-11-07

How to Cite

Rizk, S., Awheda, I. M. ., & Smida, F. A. (2019). Synthesis and DFT Study of Newly Schiff Base and Fused Heterocyclic Compounds as Antibacterial Agent. JOURNAL OF ADVANCES IN CHEMISTRY, 16, 5395–5403. https://doi.org/10.24297/jac.v16i0.8499

Issue

Vol. 16 (2019)

Section

Articles

License

Creative Commons License All articles published in Journal of Advances in Linguistics are licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)